Growth Metrics

Ironwood Pharmaceuticals (IRWD) Receivables - Other (2016 - 2020)

Ironwood Pharmaceuticals' Receivables - Other history spans 11 years, with the latest figure at $73.4 million for Q1 2020.

  • On a quarterly basis, Receivables - Other rose 5.92% to $73.4 million in Q1 2020 year-over-year; TTM through Mar 2020 was $73.4 million, a 5.92% increase, with the full-year FY2019 number at $106.0 million, up 76.73% from a year prior.
  • Receivables - Other hit $73.4 million in Q1 2020 for Ironwood Pharmaceuticals, down from $106.0 million in the prior quarter.
  • Over the last five years, Receivables - Other for IRWD hit a ceiling of $106.0 million in Q4 2019 and a floor of $50.0 million in Q1 2017.
  • Historically, Receivables - Other has averaged $68.2 million across 5 years, with a median of $65.7 million in 2018.
  • Biggest five-year swings in Receivables - Other: surged 52010.0% in 2016 and later decreased 27.2% in 2018.
  • Tracing IRWD's Receivables - Other over 5 years: stood at $63.9 million in 2016, then rose by 23.54% to $79.0 million in 2017, then fell by 24.07% to $60.0 million in 2018, then soared by 76.73% to $106.0 million in 2019, then crashed by 30.73% to $73.4 million in 2020.
  • Business Quant data shows Receivables - Other for IRWD at $73.4 million in Q1 2020, $106.0 million in Q4 2019, and $94.6 million in Q3 2019.